Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study

Summary Aims: This report describes patterns of treatment changes with the phosphodiesterase type 5 (PDE5) inhibitors tadalafil, sildenafil and vardenafil, and variables associated with those treatment changes, during the 6‐month, prospective, pan‐European Erectile Dysfunction Observational Study (...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical practice (Esher) 2007-11, Vol.61 (11), p.1850-1862
Hauptverfasser:	Hatzichristou, D., Haro, J. M., Martin-Morales, A., Von Keitz, A., Riley, A., Bertsch, J., Belger, M., Wolka, A. M., Beardsworth, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Biological and medical sciences Carbolines - therapeutic use Cohort Studies Drug therapy Erectile dysfunction Erectile Dysfunction - drug therapy Follow-Up Studies General aspects Health behavior Humans Imidazoles - therapeutic use Inhibitor drugs Male Medical sciences Mens health Middle Aged Patient Compliance Patient Satisfaction Phosphodiesterase Inhibitors - therapeutic use Piperazines - therapeutic use Prospective Studies Purines - therapeutic use Regression Analysis Severity of Illness Index Sexual disorders Sildenafil Citrate Sulfones - therapeutic use Surveys and Questionnaires Tadalafil Time Factors Treatment Outcome Triazines - therapeutic use Vardenafil Dihydrochloride
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!